Breaking News Instant updates and real-time market news.

DRNA

Dicerna

$13.76

0.6 (4.56%)

07:32
05/17/18
05/17
07:32
05/17/18
07:32

Dicerna files $250M mixed securities shelf

DRNA Dicerna
$13.76

0.6 (4.56%)

03/23/18
HCWC
03/23/18
DOWNGRADE
HCWC
Neutral
Dicerna downgraded to Neutral from Buy at H.C. Wainwright
H.C. Wainwright analyst Ed Arce downgraded Dicerna to Neutral while raising his price target for the shares to $12 from $10. The analyst cites "solely" valuation for the downgrade. The stock has "recently gotten ahead of itself" and now trades at about fair value, Arce tells investors in a research note.
03/27/18
RILY
03/27/18
INITIATION
Target $10
RILY
Neutral
Dicerna initiated with a Neutral at B. Riley FBR
B. Riley FBR analyst Madhu Kumar started Dicerna Pharmaceuticals with a Neutral rating and $10 price target. The analyst believes the company's RNAi platform is balanced by advanced clinical competition.
04/20/18
EVER
04/20/18
NO CHANGE
Target $17
EVER
Outperform
Dicerna price target raised to $17 after Alnylam settlement at Evercore ISI
Evercore ISI analyst Umer Raffat raised his price target on Dicerna (DRNA) to $17 from $14 after news that the company has resolved all litigation with Alnylam Pharmaceuticals (ALNY). "The settlement allows Dicerna to advance all of its key and planned pipeline programs while maintaining a strong balance sheet," the company said in a statement. Raffat maintains an Outperform rating on Dicerna shares.
05/01/18
HCWC
05/01/18
NO CHANGE
Target $12
HCWC
Neutral
Dicerna litigation settlement could lead to collaborations, says H.C. Wainwright
H.C. Wainwright analyst Ed Arce believes resolving all pending litigation with Alnylam (ALNY) removes an overhang on shares of Dicerna Pharmaceuticals (DRNA). The litigation with Alnylam had created an overhang on business development opportunities, likely causing perhaps three or more potential partners to decline a deal at the time, Arce tells investors in a research note. With the settlement, the analyst believes potential partners are likely to return to the negotiating table. He keeps a Neutral rating on Dicerna with a $12 price target.

TODAY'S FREE FLY STORIES

DGAZ

VelocityShares 3x Inv Natural Gas ETN

$22.23

-0.25 (-1.11%)

06:56
05/25/18
05/25
06:56
05/25/18
06:56
Technical Analysis
VelocityShares 3x Inv Natural Gas ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BKE

The Buckle

$25.75

0.65 (2.59%)

06:56
05/25/18
05/25
06:56
05/25/18
06:56
Earnings
The Buckle reports Q1 EPS 38c, consensus 36c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

UGAZ

VelocityShares 3x Long Natural Gas ETN

$68.48

0.96 (1.42%)

06:55
05/25/18
05/25
06:55
05/25/18
06:55
Technical Analysis
VelocityShares 3x Long Natural Gas ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FQVLF

First Quantum Minerals

$0.00

(0.00%)

06:55
05/25/18
05/25
06:55
05/25/18
06:55
Downgrade
First Quantum Minerals rating change  »

First Quantum Minerals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

06:55
05/25/18
05/25
06:55
05/25/18
06:55
General news
FX Action: USD-CAD clawed out an 11-day high »

FX Action: USD-CAD clawed…

EWZ

MSCI Brazil Index

$38.16

-0.52 (-1.34%)

06:54
05/25/18
05/25
06:54
05/25/18
06:54
Technical Analysis
MSCI Brazil Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFA

iShares MSCI EAFE Index Fund

$70.66

-0.26 (-0.37%)

06:54
05/25/18
05/25
06:54
05/25/18
06:54
Technical Analysis
iShares MSCI EAFE Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$46.38

1.35 (3.00%)

06:53
05/25/18
05/25
06:53
05/25/18
06:53
Hot Stocks
Foot Locker provides store base update »

During Q1, Foot Locker…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

JNK

SPDR Barclays High Yield Bond

$35.75

(0.00%)

06:53
05/25/18
05/25
06:53
05/25/18
06:53
Technical Analysis
SPDR Barclays High Yield Bond: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SJB

ProShares Short High Yield

$23.18

(0.00%)

06:53
05/25/18
05/25
06:53
05/25/18
06:53
Technical Analysis
ProShares Short High Yield: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HYG

iShares iBoxx $ High Yield Corporate Bond

$85.68

0.04 (0.05%)

06:52
05/25/18
05/25
06:52
05/25/18
06:52
Technical Analysis
iShares iBoxx $ High Yield Corporate Bond: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$115.06

0.335 (0.29%)

06:52
05/25/18
05/25
06:52
05/25/18
06:52
Technical Analysis
iShares iBoxx $ Investment Grade Corporate Bond: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$46.38

1.35 (3.00%)

06:51
05/25/18
05/25
06:51
05/25/18
06:51
Hot Stocks
Breaking Hot Stocks news story on Foot Locker »

Foot Locker up 10.6%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

DIS

Disney

$102.10

-0.8 (-0.78%)

06:51
05/25/18
05/25
06:51
05/25/18
06:51
Periodicals
ESPN's political expression strained relationship with Disney, WSJ reports »

Executives at ESPN have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLT

iShares 20+ Year Treasury Bond Fund

$118.87

0.93 (0.79%)

06:51
05/25/18
05/25
06:51
05/25/18
06:51
Technical Analysis
iShares 20+ Year Treasury Bond Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$46.38

1.35 (3.00%)

06:51
05/25/18
05/25
06:51
05/25/18
06:51
Hot Stocks
Foot Locker backs FY18 SSS guidance of positive growth »

"The flow of premium…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

SLV

iShares Silver Trust

$15.69

0.19 (1.23%)

06:51
05/25/18
05/25
06:51
05/25/18
06:51
Technical Analysis
iShares Silver Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LH

LabCorp

$175.31

-0.27 (-0.15%)

, DGX

Quest Diagnostics

$100.89

-0.34 (-0.34%)

06:51
05/25/18
05/25
06:51
05/25/18
06:51
Recommendations
LabCorp, Quest Diagnostics, UnitedHealth, Aetna analyst commentary  »

Barclays boosts price…

LH

LabCorp

$175.31

-0.27 (-0.15%)

DGX

Quest Diagnostics

$100.89

-0.34 (-0.34%)

UNH

UnitedHealth

$242.73

-1.48 (-0.61%)

AET

Aetna

$177.05

-0.31 (-0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 12

    Jun

USLV

VelocityShares 3x Long Silver ETN

$10.26

0.38 (3.85%)

06:50
05/25/18
05/25
06:50
05/25/18
06:50
Technical Analysis
VelocityShares 3x Long Silver ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYR

DJ US Real Estate Index Fund

$76.81

-0.21 (-0.27%)

06:50
05/25/18
05/25
06:50
05/25/18
06:50
Technical Analysis
DJ US Real Estate Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$46.38

1.35 (3.00%)

06:49
05/25/18
05/25
06:49
05/25/18
06:49
Hot Stocks
Foot Locker reports Q1 gross margin rate 32.9% vs. 34% last year »

Foot Locker gross margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

IBB

iShares Nasdaq Biotechnology Index

$107.25

-0.06 (-0.06%)

06:49
05/25/18
05/25
06:49
05/25/18
06:49
Technical Analysis
iShares Nasdaq Biotechnology Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LABD

Daily S&P Biotech Bear 3x Shares

$28.70

-0.4 (-1.37%)

06:49
05/25/18
05/25
06:49
05/25/18
06:49
Technical Analysis
Daily S&P Biotech Bear 3x Shares: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWH

MSCI Hong Kong Index

$26.03

-0.095 (-0.36%)

06:48
05/25/18
05/25
06:48
05/25/18
06:48
Technical Analysis
MSCI Hong Kong Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWG

iShares MSCI Germany

$32.28

-0.25 (-0.77%)

06:48
05/25/18
05/25
06:48
05/25/18
06:48
Technical Analysis
iShares MSCI Germany: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.